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Abstract A cDNA encoding a receptor for the oxytocin-related 
peptide isotocin has been identified by screening a lambda gtl l  
library constructed from poly(A) ÷ RNA of the hypothalamic re- 
gion of the teleost Catostomus commersonL The probe used was 
obtained by PCR amplification of white sucker genomic DNA 
using degenerate primers based on conserved sequences in the 
mammalian receptor counterparts. The full-length eDNA speci- 
fies a polypeptide of 390 amino acid residues that displays the 
typical hydrophobicity profile of a seven transmembrane domain 
receptor and which exhibits greatest similarity to mammalian 
oxytocin receptors. Oocytes that express the cloned receptor 
respond to the application of isotocin by an induction of mem- 
brane chloride currents indicating that it is coupled to the inositol 
phosphate/calcium pathway. The isotocin receptor (ITR) can also 
be activated by vasotocin, mesotocin, oxytocin and Arg-vaso- 
pressin, although these have lower potencies than isotocin. ITR- 
encoding mRNA has been detected in brain, intestine, bladder, 
skeletal muscle, lateral line, gills and kidney indicating that this 
receptor may mediate a variety of physiological functions. 
Key words': Neuropeptide; Oxytocin receptor; 
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I. Introduction 
The mammalian neurohypophyseal nonapeptide hormones 
vasopressin (VP) and oxytocin (OT), and their cognate recep- 
tors, are involved in a variety of functions such as the regulation 
of osmotic balance and blood pressure (VP), and the contrac- 
tion of uterine and mammary smooth muscle during birth and 
lactation (OT). The functional roles of their non-mammalian 
counterparts vasotocin and isotocin/mesotocin areless well de- 
fined. However, recent binding, in situ hybridization, and phys- 
iological studies uggest that these peptides mediate a number 
of diverse activities in lower vertebrates including reproductive, 
renal, cardiovascular, metabolic, and hydroosmotic functions; 
in addition, they may play a role in urine excretion and in the 
modulation of neurotransmission [1-10]. This broad range of 
physiological effects and the observation of diverse signal 
transduction pathways point to the existence of a number of 
nonapeptide r ceptor subtypes in non-mammalian species. Re- 
*Corresponding author. Fax: (49) (40) 4717-4541. 
Abbreviations: ITR, isotocin receptor; VTR, Arg-vasotocin receptor; 
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cently an Arg-vasotocin receptor has been cloned from the 
teleost fish white sucker, Catostomus commersoni [11] by PCR 
amplification using degenerate oligonucleotide primers based 
on conserved regions of the mammalian vasopressin Vla, and 
V2 and oxytocin receptors [12-18]. We report here on the iden- 
tification of a teleostean isotocin receptor ~,its primary struc- 
ture and functional properties. 
2. Materials and methods 
2.1. Materials 
Nonapeptides were obtained from Saxon Biochemicals (Hannover, 
Germany). Taq DNA polymerase, a T7 RNA polymerase transcription 
kit from Promega Biotec (Madison, WI, USA), RNAzol B from Bio- 
tecx Lab. Inc. (Houston, TX, USA), and RNAsin and DNAse I from 
Boehringer (Mannheim, Germany). 
2.2. Cloning of the isotocin receptor 
Degenerate PCR primers based on conserved sequences of mammal- 
ian nonapeptide r ceptors were used to amplify C. commersoni genomic 
DNA [11]. Fragments ofabout 0.35 kb in size were cloned into the PstI 
restriction site of pBluescript and sequenced. One clone that displayed 
greatest equence similarity to mammalian oxytocin receptor sequences 
was labelled with [3zP]CTP and used for screening (3 x 108 dpm//2g 
DNA, 1 x 10 6 dpm/ml of hybridization buffer) a C. commersoni hy- 
pothalamic lambda gtl 1 cDNA library (3 x 10 6 recombinant phages, 
5 x 104 plaque forming units per plate). One positive clone (ITR) was 
isolated, its 3.1 kb insert subcloned into pBluescript, and subjected to
automated DNA sequencing (Applied Biosystems Model 373 A) with 
dye-labelled primers and dye terminators. 
2.3. Functional expression i  ooeytes 
Synthesis of in vitro transcribed RNA was carried out using, as 
template, pBluescript containing the ITR cDNA linearized at the SalI 
restriction site present in the vector polylinker and a T7 RNA polym- 
erase transcription kit (using the protocol of the manufacture). RNA 
was dissolved in H20 (40 ng//21) and injected (50 nl) into stage V 
Xenopus Iaevis oocytes. Oocytes were kept at 20°C for two to three 
days. Voltage clamp measurements were performed with a conven- 
tional two-electrode voltage clamp (CA 100, VF 1800, VF 180, Biologic, 
Claix, France) at room temperature. Membrane currents were elicited 
by a I rain application of peptide agonists to the injected oocytes. 
2.4. mRNA distribution 
Total RNA was extracted from various white sucker tissues using 
RNAzol B. 100/21 containig 2/2g of total RNA and 64 units of RNAsin 
were incubated with 10 units of DNAse I at 37°C for 30 min. RNA was 
extracted with phenol and chloroform, ethanol precipitated, issolved 
in H20 and converted into single-stranded cDNA using oligo(dT) by 
reverse transcription [19]. Forward (positions 941-961) and reverse 
(positions 1346-1366) primers (1/2M each) corresponding to the ITR 
cDNA sequence (Fig. 1) were mployed inthe PCR (2.5 units Taq DNA 
polymerase/100/21; 35 cycles at 94°C for 1 rain, 55°C for 1 min, and 
tThe sequence r ported in this paper has been deposited in the Gen- 
Bank database (accession no. X87783). 
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72°C for 1 min) with 1/20th of the single-stranded cDNA. Following 
agarose gel electrophoresis, fragments were blotted onto nylon mem- 
branes and hybridized under stringent conditions (final wash, 65°C, for 
1 h, in 0.1 × SSC, 0.1% SDS; ref. [19]) with a riP-labelled ITR eDNA 
probe. 
3. Results and discussion 
3.1. Cloning and structure of  the isotocin receptor 
Using degenerate primers based on DNA sequences encod- 
ing the second extracellular loop and transmembrane domain 
VI of mammalian onapeptide receptors [12-18], a eDNA frag- 
ment has been amplified the specified product of which exhibits 
greatest similarity to mammalian oxytocin receptors. Using this 
fragment as a probe a cDNA clone of 3152 bp has been isolated 
from a C. commersoni hypothalamic DNA library (Fig. 1). 
This includes 213 bp of 5'-untranslated and 1769 bp of 3'- 
untranslated sequence. The presence of a short stretch of 9 
adenine residues that are 21 nucleotides downstream of a ca- 
nonical polyadenylation signal suggests that the complete Y 
end has been cloned. An open reading frame of 1170 bp predicts 
a protein of 390 amino acid residues with a molecular weight 
of 44487 Da. 
Hydrophobicity analysis of the deduced amino acid sequence 
indicates the presence of seven putative transmembrane regions 
that are characteristic of G-protein coupled receptors. The se- 
quence displays a high degree of similarity to mammalian 
oxytocin receptors and shares several features with these recep- 
tors that are not found in vasotocin and vasopressin receptors 
such as an Asp-Arg-Cys variation of the conserved Asp-Arg- 
Tyr motif at the end of transmembrane region III. As shown 
in Fig. 1 the ITR displays several other characteristics of G- 
protein coupled receptors such as (i) N-linked glycosylation 
sites in its N-terminal extracellular domain (Asn-14, -19, -24, 
-30), (ii) consensus equences for phosphorylation by protein 
kinase C (Thr/Ser-X-Arg/Lys) in the first (positions 70-72) and 
third (positions 239-241,262-264, 273-275) intracellular loops 
and in the C-terminal intracellular tail (positions 365-367, 380- 
382), (iii) for protein kinase A (Arg-X-Ser/Thr) in the third 
intracellular loop (positions 259-261) and in the cytoplasmic 
tail (positions 366-368), and (iv) for casein kinase 1I (Thr/Ser- 
X-X-Asp/Glu) in the third intracellular loop (positions 239- 
242). A cysteine doublet 14 residues after transmembrane do- 
main VII may be modified by palmitoylation and may thereby 
anchor the cytoplasmic tail in the lipid bilayer [20]. Sequence 
ACGGGACAGCAAGTGAAGGACCTGCTAAAATGGATAATAATCGTTGAAAGCAACTGAGGGATCACCACCAAACAG TAAAGGTCCCAGTGT - 124 
ATCCAAATCTCTCGGGTGACACCTGTTAGGCTATTTTAAATTAACTGGCTGAATATGCGCGAGGAAAGCTTGTCGGTCTATTGATACATT - 34 
TATGGAGAAGTAGACGTGCTCTTTTCTGGCATCATGGAGGAGATGTTCAAGGAGCAAGACTTTTC.GTCCTTCAACGAATCATCTAGAAAC 57 
M E E M F K E Q D F W S F N E S S R N 19 
TCCACCGTCGGCAATGAGACCTTTGGTGGGAACCAGAC AGTG AATCCCCTG AAG AG AAAq G AAG AGGTGGCCAAAGTAG AAGTTACTG TG 147 
S T V G N E T F G G N Q T V N P L K R N E E V A K V E V T V 49 
CTTGCCTTGGTGCTGTTTTTGGCTCTTGCTGGTAACCTATGCGTCCTTATTGCGATCTACACAGC•AAGCACACTcAATCGCGCATGTAT 237 
L A L V L F L A L A G N L C V L I A I Y T A K H T Q S R M Y 79 
TACCTCATGAAGCACCTCAGCATTGcAGATCTGGTGGTGGCTGTCTTCCAGGTTCTGCCTCAACTCATTTGGGACATCACCTTTCGCTTC 327 
Y L M K H L S I A D L V V A V F O V L P O L I W D I T F R F 109 
TATGGGCCAGACTTCCTTTGCAGGTTC43TAAAATATCTCCAGACCGTCGGGATGTTCGCCTCCACTTACATGCTCGTGCTGATGTCCATA 417 
Y G P D F L C R L V K Y L Q T V G M F A S T Y M L V L • ~ T 139 
GACAGATGTATTGCTATCTGTCAGCCCCTTCGTTCTTTACACAAGCGAAAGGACCGCTGTTATGTGATTG~TTTCTTGGGCACTGAGCTTA 507 
D R C I A ~ C Q P L R S L H K R K D R C Y V I V S W A L S L 169 
GTTTTCAGTGTCCCACAAGTTTATATATTCTCCTTACGTGAGATTGGTAATGGAGTCTACGATTGCTGGGGAGATTTCGTCCAGCCTTGG 597 
V F S V P O V Y I F S L R E I G N G V Y D C W G D F V Q P W 199 
GGAGCAAAAGCCTACATTACATGGATAAGTCTGACAATATACATCATACCAGTGGCCATACTGGGTGGC TGCTATGGACTGATAAGCTTT 687 
G A K A Y I T W I S L T I Y I I P V A I L G G C Y G L I S F 229 
AAAATATGGCAAAACTTTAAAAGGAAAACGAAGAAGGAC•AGTGTATCACTCT•ACAACTGCGGCATCGAAAGC•AACGCG•TCGCGCGG 777 
K I W Q N F K R K T K K D Q C I T L T T A A S K A N A L A R 259 
"0 
GTCAGCAGCGTCAAACTCGTTTCCAAGGCCAAAATCACCACCGTTAAAATGACTTTTGTTATTGTGCTGGCTTATATAGTTTGCTGGACT 867 
V S S V K L V S K A K I T T V K M T F V I V L A Y I V C W T 289 
CCGTTTTTCTTCGTACAGATGTGGTCAGCCTGGGATCCAGAAGCACCAAGGGAAGCCATGCCCTTTATCATCTCCATGTTACTGGCTAGC 957 
P F F F V Q M W S A W D P E A P R E A M P F I I S M L L A S 319 
CTGAACAGCTGCTGTAACCCCTGGATCTACATGTTTTTCGCCGGGCATCTA~FCCACGACCTGAAGCAGAGCCTGCTGTGTTGTTCCACA 1047 
L N S C C N P W I y M F F A G H L F H D L K Q S L L C C S T 349 
D 
CTGTATCTAAAGTCTTCTCAGTGTCGTTGTGATCAGGAACACGACTCACGCAAGAGCAACTGCTCCACCTATGTCATTAAAAGCACCAGC 1137 
L Y L K S S Q C R C D Q E H D S R K S N C S T Y V I K S T S 379 
# 
AGCCAGAGGAGCATCACCCAGTCTTCCATCACATAATCATATACAATTATTTGGACGTTq TGAAAGCCTGGGAGATTCAGATGAAGGAAA 1227 
S Q R S I T Q S S I T 390 
GGACAATTAAAAACAGTAACCCAAAGTCTCCAAATCTCACTATGAAGTTAACATCAGTAq TGTTTTCTTTTGGGAATTATCCATTCCCAA 1317 
TGCAATTTCAATCACTCCACTT~TTTGCACTCCTTTTCTGGAAACTCCCTATAATTTTC~TATCTCTTAAGATCCTTGAGGAGCAACAAA 1407 
ACGAAGACAGAGTAAATTGTTCCTTACCTTGTGGACTATGTTTATGAGATGTAAACATC.GGAAAGATCCTGAATTTCTTAAAGTTGTACC 1497 
AAGAACATGTCTGTTGAAATTGGAATGTATTACACAGCTTTGTTTTTTAATTGCAGAGCTCAAGTGGAGGAATTTGAT•CGCCCTCTGCC 1587 
GTTTTGAGAGTACATACAAGAAGAAAATAATGCCTTTCATCTTTAATGGTGCGTTCACGTACAACACGCGGCAAAGTCAATGCAAAGATG 1677 
CGAATAGACGCCA/~TCCGCATGACGCTT~TcGCGAAAGTCq~AGCATTCGAGA~q~PCAGGATGTCACTGACGTAATGACGTACT 1767 
GATGTAGTTGCAGTAGAAATCTGGAACAAATACGCGAATGAAGCGATTTCACGTGTTCT~GTTCACGTGTTCATTCATTTCATTCACGAC 1857 
ATCCGGCGCGAATTCGCGTCTATTCGCAT•TTTGCATTGA•TTTTTATGTAATCGCGCCGTGCG•AACGACTCGTTTCG•GTTGTATGTG 1947 
AACGCACCATTAGACTTCACGTCAACA•CCC•AAAAATACTAATTCATGAAAAAGAAACAGTAGAGAAAAATATTTTTTTCACTGATCAA 2037 
GTTTGACATATTCTGAAGTGGACATCAGGATCATGCCATTTTATACATCAAAAACTGTTTGT•AGAATGCAAAACATCTCATGGATTTGA 2127 
GAACCCACAGATGA~GAAGATGCTGAAGACACATAAAGTGT~AAATCCCCTCTATTq CATTCCGAACCCAATGACAAACATGGCAAG 2217 
TTGCTCTTTTAATGGTCTTTTACAAGAGAACACTGACAAATATTTATTTAAAAAAAAATCATAACGAACACAAGCACTTTTGACTATTTT 2307 
GTCACATAGACATTCATGTTGTTGTCACCGTTCTq~AGTATTCATGTAAACAACAAAAC~ GTCATGCCCAGAGGCCTATATACATTqX3CA 2397 
TAATGTTTCT(3CAATGCATCATTGTAACCAAATATTC-GTTT~TTGTTTAAGTTAAAGA~TTGCTGTTCCTCCTTTCCATTTTATTGTTG 2487 
TTAGTCTTGTAAGTTTATTCCAGTTCAATATTTTTACTTATTGCTCTAAAAACAATGCTTTAAGTCTA~TTGCTGCATCTCCATA 2577 
AATTATTTTCTAAAGTAAACACTCAAGAGGACAAGCACATTTAACACAGTTATTTACTAGTGCTGCAAGAAAGAAAATCTGC••1q•rACTT  2667 
TTTAAGGAAAATGATAAAGGCAGTTTTATCAGCAGAAGATTTATTTTA•AATGTTTAAATA•ACTATTCACTGAAGCTCTGTTAGTCTCT 2757 
CATTTATAAAGCTACTGATTTTTAcTCcTGAAAAAATATACTGcATATTTA•ATTTAAGATGCGTAGATGTAGTG•TTATTTATTTAAAT 2847
AAATTG AATGTGTTGATACG TC TAAAAAAAAA 2879 
Fig. 1. Nucleotide and deduced amino acid sequence (single letter code) of the C commersoni isotocin receptor. Transmembrane r gions are 
underlined, N-linked glycosylation sites are indicated by *, potential phosphorylation sites for protein kinase C by e, for protein kinase A by #, for 
casein kinase li by <>, and a putative palmitoylation site by +. 
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Fig. 2. Tissue distribution of ITR transcripts (for details ee section 2). 
R.O., reproductive organs; control, reverse transcription and amplifica- 
tion in the absence of RNA. Not shown are negative controls where 
VTR cDNA run on an agarose gel and blotted onto a nylon membrane 
failed to give hybridization signals with a 32P-labelled ITR cDNA 
probe; no amplified fragment was obtained when using the ITR for- 
ward and reverse primers and the VTR cDNA as template. 
analyses also reveal the presence of residues that are conserved 
among nonapeptide r ceptors but which are absent from other 
G-protein coupled receptors. Residues Phe-Gln-Val-Leu-Pro- 
Gln-Leu at the C-terminal end of transmembrane region II, 
Gly-Pro-Asp in the first and Asp-Cys-Trp and Pro-Trp-Gly in 
the second extracellular loops have been suggested to contrib- 
ute to the ligand binding domain [21]. 
3.2. Functional expression in Xenopus laevis oocytes 
Oocytes previously injected with ITR-RNA respond to bath 
application of isotocin by exhibiting large chloride currents 
indicating the coupling of the ITR to the inositol phosphate/ 
Ca 2÷ signalling pathway (Table 1). The threshold concentration 
of IT that induced a significant membrane current of 1 to 5 nA 
was 2 + 1.5 nM and the EC~0 value for this agonist was 80 + 30 
nM. The teleost ITR can also be activated by Arg-vasotocin, 
mesotocin, oxytocin and Arg-vasopressin, although these have 
lower potencies than IT. It is interesting to note that the ITR 
differs in several respects from the previously cloned vasotocin 
receptor (VTR). Firstly, the VTR has a high peptide selectivity; 
the threshold for its activation by IT and corresponding ECs0 
value are about 10000-fold higher than those for VT [11]. In 
contrast, the ITR displays only a three-fold preference for IT 
compared to VT. Secondly, the rank order of potencies being 
oxytocin > mesotocin >Arg-vasopressin for the VTR and 
mesotocin >oxytocin > Arg-vasopressin for the ITR. Thirdly, 
the concentrations of agonists needed to induce membrane 
currents in RNA injected oocytes is about 100-fold higher for 
the ITR than for the VTR. 
3.3. ITR mRNA distribution 
RNA blot analyses with either total RNA or poly(A) ÷ RNA 
from different C. commersoni t ssues and riP-labelled ITR- 
cDNA probe failed to reveal bands indicating that the ITR 
mRNA is of low abundance in the tissues examined. Therefore 
reverse transcribed RNA was amplified using primers pecific 
for the white sucker ITR nucleotide sequence. Fig. 2 shows that 
ITR transcripts are present in brain, spleen, lateral line, ovary, 
bladder, intestine, heart and liver; products are also detectable 
in skeletal muscle, gills and kidney. In some lanes double bands 
can be seen suggesting the existence of ITR isoforms. 
3.4. Phylogeny of the nonapeptide receptors 
Fig. 3 shows that, based on sequences, the known nonapep- 
tide receptors fall into four major groups. The ITR is most 
closely related to mammalian oxytocin receptors; it is also re- 
lated to the human Vlb receptor. The fish VTR and the mam- 
malian Via receptors form a second group being related to the 
third, the V2 receptor group. A fourth group having only a low 
degree of sequence similarity with the IT/OT receptor and the 
VT/VP receptor subfamilies consists of the conopressin recep- 
tors recently cloned from the pond snail Lymnaea stagnalis [24] 
suggesting that the molluscan genes eparated early in evolu- 
tion probably before the separation ofthe other members of the 
nonapeptide r ceptor family. Based on the divergence ofamino 
acid sequences the VT/V~a receptors and the V2 receptors may 
have emerged by duplication of an ancestral neurohypophyseal 
hormone receptor gene about 640 million years ago, before the 
Table 1 
Pharmacological haracterization f the white sucker isotocin receptor (ITR) expressed in Xenopus laevis oocytes 
A 
xsotocin 
ITR ECso 
B active peptides values [nM] 
isotocin 
Arg-vasotocin 
oxytocin 
mesotocin 
Arg-vasopressin 
inactive peptides 
CYISNCPIG*  80 + 30 
CY IQNCPRG* 300 + 90 
CY IQNCPLG*  950 + 420 
CY IQNCPIG*  440 + 110 
CYFQNCPRG* 3500 + 2100 
conopress in  S C I  IRNCPRG*  --- 
conopress in  G CF IRNCPKG*  ---  
toc ino ic  ac id  CY IQNC ---  
(A) Typical membrane current race of an oocyte injected with 2 ng of ITR-RNA, incubated as described insection 2, and then exposed for 1 min 
(bar) to 300 nM isotocin. Membrane currents were recorded at a holding potential of-50 inV. (B) The indicated ligands were applied at concentrations 
ranging from 1 nM to 10/2M for 1 min to the voltage-clamped oocytes. For the calculation of ECs0 values dose-response curves were constructed 
(data not shown). Membrane currents were integrated over time; these values were then expressed relative to the maximal transported charge and 
plotted semilogarithmically versus ligand concentration. Each ECs0 value derives from three to six experiments. Maximal amplitudes ofthe induced 
currents were 710+290 hA. For those peptides for which no ECs0 values are given, the ITR was not activated at concentrations of 10/2M (---). 
G *, amidated glycine residue. 
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hV2R 
rV2R 
pLysV2R 
rV laR  
hV laR  
fVTR 
hOTR 
rOTR 
pOTR 
f ITR 
hV lbR  
IsCPR 1 
lsCPR2 
Fig. 3. Sequence relationships of the nonapeptide r ceptor family de- 
picted in the form of a dendrogram. The amino acid sequences of the 
various receptors were aligned using the PILEUP algorithm (Genetics 
Computer Group, Madison, WI, USA). The lengths of the horizontal 
lines indicate reciprocally the sequence similarities, hV2R, human Arg- 
vasopressin V2 receptor [15]; rV2R, rat Arg-vasopressin V2 receptor 
[14]; pLysV2R, pig Lys-vasopressin V2 receptor [17]; rVlaR, rat Arg- 
vasopressin Vla receptor [12]; hVlaR, human Arg-vasopressin Vla 
receptor [13]; fVTR, fish (C. commersoni) Arg-vasotocin receptor [11]; 
hOTR, human oxytocin receptor [18]; rOTR, rat oxytocin receptor [22]; 
pOTR, pig oxytocin receptor [17]; fITR, fish (C. commersom) isotocin 
receptor; hV1 bR, human Arg-vasopressin V 1b receptor [23]; LSCPR L 
Lymnaea stagnalis conopressin receptor 1[24]; LSCPR2, Lymnaea stag- 
nalis conopressin receptor 2 (van Kesteren et al., manuscript submit- 
ted). 
separation of the cyclostomes from other vertebrates. The IT/ 
OT receptors evolved later, about 460 million years ago before 
cartilaginous fish originated. Thus, OT-like receptors hould be 
present in all non-mammalian vertebrates except for cyclo- 
stomes; this is indeed consistent with the presence of OT-like 
peptides in non-mammalian vertebrates [25]. 
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